Product Information
DEXTROAMP-AMPHET ER 5 MG CAP is a generic product labeled by Lannett Company Inc., priced at $0.4393 per EA under NDC 00527551037. Its NADAC has been published 267 times since Oct 21, 2020.
FDA first approved this application on Dec 11, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 5 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527551037
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037FDA Approved
12/11/2019
TE Code
AB1
On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has been published 267 times since Oct 21, 2020, and over the history we have for it it has declined 49.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4393 per EA |
|---|---|
| All-time high | $0.9097 (Dec 13, 2023) |
| All-time low | $0.3459 (Apr 17, 2024) |
| 52-week high | $0.6090 |
| 52-week low | $0.4393 |
| Median price | $0.6090 |
| Average price | $0.6283 |
| Largest weekly change | +62.9% (Oct 18, 2023) |
| Weeks tracked | 267 |
| Tracking since | Oct 21, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-27.9%
3Y
-25.1%
5Y
-33.1%
All
-49.4%
Last surveyed Nov 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 5 MG CAP, manufactured by Lannett Company Inc., is $0.4393 per EA (NDC 00527551037), effective Nov 26, 2025.
How has the price of DEXTROAMP-AMPHET ER 5 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has declined 49.4%. It has been tracked across 267 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 5 MG CAP?
Since Oct 21, 2020, the NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has ranged from a low of $0.3459 (Apr 17, 2024) to a high of $0.9097 (Dec 13, 2023), with a median of $0.6090 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 5 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 5 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 5 MG CAP?
DEXTROAMP-AMPHET ER 5 MG CAP (NDC 00527551037) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.